Clinical Trials Browser

Phase 2 × NETWORK × Trabectedin × Clear all

NCT04305548 2026-03-27

ISG-MCS

Phase 2 Recruiting

Chondrosarcoma, Mesenchymal

NCT04383119 2026-03-25

ISG-ARTICLE

Phase 2 Recruiting

Sarcoma

NCT02234050 2025-07-10

Trabectedin for Recurrent Grade II/III Meningioma

Phase 2 Completed

90 enrolled 18 charts

Recurrent High Grade Meningioma

NCT03023124 2024-12-09

STRADA

Phase 2 Completed

Solitary Fibrous Tumors

NCT02247544 2021-11-01

TRAVELL

Phase 2 Completed

Leiomyosarcoma, Liposarcoma, Ichthyosis, X-Linked

NCT00070109 2018-09-14

Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors

Phase 2 Completed

50 enrolled 18 charts

Sarcoma, Ewing, Neuroectodermal Tumors, Primitive, Peripheral

NCT00569673 2018-07-18

Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer

Phase 2 Completed

71 enrolled 8 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02066675 2018-04-11

TR1US

Phase 2 Completed

Neoplasm Metastasis, Soft Tissue Neoplasms

NCT00379145 2017-12-12

Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus

Phase 2 Completed

20 enrolled 7 charts

Sarcoma

NCT00003939 2012-09-24

Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma

Phase 2 Completed

CNSGastrointestinalGynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Ovarian Neoplasms, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Central Nervous System Neoplasms, Endometrial Neoplasms, Sarcoma, Endometrial Stromal, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Gastrointestinal Stromal Tumors, Histiocytoma, Malignant Fibrous